If You Invested in Nexentis Technologies Inc. (NXTS)
Looking for the current price? See the NXTS quote & overviewWhat $1,000 or $10,000 in NXTS Would Be Worth Now
Real historical value by amount invested and how long ago| If you invested | 1 year ago | 5 years ago | 10 years ago | Since May 14, 2021 |
|---|---|---|---|---|
| $1,000 | $23 -98% | $0.04 -99.99% | — | $0.03 -99.99% |
| $10,000 | $226 -98% | $0.36 -99.99% | — | $0.26 -99.99% |
Based on real historical closing prices adjusted for stock splits, without dividends, through 2026-11-05. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results. We start NXTS on May 14, 2021 because the prices we hold from before that date cannot be compared with the later ones, and a return measured across the two would be wrong.
Custom Calculation
Choose your own date and amount for NXTS$1,000 Investment Over Time
NXTS vs S&P 500Year-by-Year Returns
NXTS annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2021May 14, 2021 to Dec 31, 2021 | $18,436.25 | $6,877.15 | -62.7% | -62.7% |
| 2022 | $6,877.15 | $1,294.83 | -81.2% | -93.0% |
| 2023 | $1,294.83 | $490.00 | -62.2% | -97.3% |
| 2024 | $490.00 | $60.76 | -87.6% | -99.7% |
| 2025 | $60.76 | $11.76 | -80.6% | -99.9% |
| 2026Dec 31, 2025 to Nov 5, 2026 | $11.76 | $0.4815 | -95.9% | -99.99% |
About Nexentis Technologies Inc.
Basic Materials · NASDAQ
Nexentis Technologies Inc. is a Nasdaq-listed operating company focused on biotechnology drug discovery and solar energy asset investments. The company describes itself as a drug discovery company that also invests in solar energy assets using a Ready to Build business model. Its common stock trades on the Nasdaq Capital Market under the symbol NXTS, and the company is incorporated in Nevada with corporate operations identified in Neve Yarak, Israel.
The company’s biotechnology activity is conducted through its wholly owned subsidiary, MitoCareX Bio Ltd. MitoCareX is focused on mitochondrial drug discovery, including therapeutic programs for inflammatory metabolic diseases and cancer that target specific metabolic pathways. Its proprietary algorithm platform, MITOLINE™, is a sequence analysis and alignment algorithm designed to prepare mitochondrial carrier proteins of the SLC25 family for 3D homology modeling. The platform is intended to address the lack of solved three-dimensional structures for many human mitochondrial carriers by aligning and annotating amino acid sequences and residues for comparative modeling.
Nexentis also reports an investment focus in solar energy assets based on the RTB model, which refers to projects that are ready to build. In addition, the company controls approximately 98% of Save Foods Ltd., an Israeli company focused on post-harvest treatment technologies designed to reduce pathogen contamination in fruits and vegetables.
The company’s public-company record includes capital-structure actions and shareholder approvals. In April 2026, Nexentis effected a one-for-seven reverse stock split of its common stock, after which the shares continued trading on Nasdaq under the NXTS symbol with a new CUSIP number. Its proxy and current-report disclosures also cover stockholder voting matters, Nasdaq Marketplace Rule 5635(d) equity-issuance approvals, material agreements, and amendments affecting common-stock rights.
Similar Stocks
See how related companies performed
Frequently Asked Questions
Nexentis Technologies Inc. investment returns
How much would $1,000 invested in Nexentis Technologies Inc. be worth today?
If you invested $1,000 in Nexentis Technologies Inc. (NXTS) 5 years ago on 2021-11-08, your investment would be worth $0.04 as of 2026-11-05, a -99.99% price return without dividends, growing at a compounded rate of -87.2% per year (CAGR).
Has Nexentis Technologies Inc. outperformed the S&P 500?
Comparison data requires at least 10 years of trading history. Use the calculator above to compare NXTS performance over available time periods.
What is Nexentis Technologies Inc.'s average annual return?
The compound annual growth rate (CAGR) of NXTS’s share price over the past 5 years is -87.2%, without dividends. Individual years vary a great deal, and NXTS’s best recent full year was 2023 (-62.2%) while the worst was 2024 (-87.6%).
For informational and educational purposes only, not investment advice.
